Stripe for SARMs vs. multiflow

Stripe's restricted-businesses page prohibits "research chemicals" and "unapproved supplements, including SARMs, peptides, nootropics not approved by the FDA for the advertised use." This is the document your business signed against when opening a Stripe account. If your product sheet includes RAD-140, LGD-4033, MK-677, Ostarine, or any SARM trading name, your account is out of policy the moment it processes one transaction.

Stripe enforces this in three ways: keyword crawl on public product pages, pattern matching MCC codes against transaction descriptions, and inbound chargeback reason codes that reveal the product category. A SARMs brand averaging $20k/mo typically gets 60–120 days before one of these triggers the review.

We underwrite SARMs as a research-chemical category with a high-risk-capable acquirer that prices the risk directly. Your application includes product list, COA program, research-only site compliance, and chargeback history. Approval comes in 48–96 hours with a real rate and a negotiated reserve based on your history, not a teaser rate that implodes at month 4.

Rate lands in the 6–8% band for most SARMs portfolios. Reserve usually 5–10% rolling for 90 days. These are real operator numbers, not aspirational brochure numbers. They reflect card-scheme risk pricing for the vertical.

Checkout stays fast and modern. Apple Pay works on approved domains. Subscriptions and auto-ship run through the native acquirer subscription engine. Customer receipts show the brand, not "multiflow."

Stripe architecture requires one merchant account per business. A 4-brand SARMs operator trying to stay on Stripe creates four separate accounts with four separate KYCs, four dashboards, four shutoff timelines. Once one goes down, the others get flagged via ownership pattern matching inside Stripe.

multiflow uses one parent acquirer with per-brand soft descriptors, per-brand Apple Pay domains, per-brand refund flows, and one consolidated settlement report. Your customers still see "StackLabs" on their statement when they bought from StackLabs, even though four SARMs brands are clearing through the same parent relationship. Reconciliation runs from one dashboard with brand/SKU filters.

We will not place SARMs on a processor that doesn't approve the vertical in writing. We will not tell you to "try Stripe first, get shut down, then come to us" — that's how merchants end up MATCH-listed. We will not pretend rates are 2.9% for a vertical that is legitimately priced 6–8%.

If your budget only works at Stripe rates, SARMs may not be the vertical for you, or you need to rebuild unit economics around the real processor cost. We'll tell you that before onboarding instead of discovering it together at month 6.

For SARMs e-commerce: Stripe is a ticking clock. multiflow is priced to stay online. If the rate math only works at 2.9%, something else has to change — either the vertical, the basket size, or the channel mix. We talk through that in the application review.

Full vertical breakdown: SARMs payment processing. Pricing: 5.5–7.5% + setup fee. Start: apply here.